These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 298350)

  • 1. Visual evoked potentials as a predictor of reported side effects during a trial of zimelidine vs. placebo in chronic pain patients.
    von Knorring L; Johansson F
    Psychiatry Res; 1979 Dec; 1(3):225-30. PubMed ID: 298350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the augmenter-reducer tendency and in pain measures as a result of treatment with a serotonin-reuptake inhibitor--zimelidine.
    von Knorring L; Johansson F
    Neuropsychobiology; 1980; 6(6):313-8. PubMed ID: 6449679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression.
    Georgotas A; Krakowski M; Gershon S
    Am J Psychiatry; 1982 Aug; 139(8):1057-8. PubMed ID: 6211994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An examination of possible interactions between zimelidine, a serotonin uptake inhibitor, and ethanol ingested conjointly in human subjects.
    Brown ZW; Amit Z; Sutherland A; Rockman G; Selvaggi N; Ogren SO
    Neurosci Lett; 1981 Dec; 27(3):351-5. PubMed ID: 6460207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zimelidine: a placebo-controlled trial in depression.
    Norman TR; Burrows GD; Marriott PF; McIntyre IM; Davies BM; Moore RG
    Psychiatry Res; 1983 Feb; 8(2):95-103. PubMed ID: 6222387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of phobic anxiety by zimelidine.
    Evans L; Moore G
    Acta Psychiatr Scand Suppl; 1981; 290():342-5. PubMed ID: 6452800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of zimelidine and desipramine in endogenous depression.
    Lingjaerde O; Bratfos O; Bratlid T; Haug JO
    Acta Psychiatr Scand; 1983 Jul; 68(1):22-30. PubMed ID: 6225313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in endorphins and 5-hydroxyindoleacetic acid in cerebrospinal fluid as a result of treatment with a serotonin reuptake inhibitor (zimelidine) in chronic pain patients.
    Johansson F; von Knorring L; Sedvall G; Terenius L
    Psychiatry Res; 1980 May; 2(2):167-72. PubMed ID: 6158065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe headache and disturbed liver function during treatment with zimelidine.
    Clarke IM
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1425. PubMed ID: 6215969
    [No Abstract]   [Full Text] [Related]  

  • 11. Zimelidine - a serotonin uptake blocker in the treatment of phobic anxiety.
    Evans L; Best J; Moore G; Cox J
    Prog Neuropsychopharmacol; 1980; 4(1):75-9. PubMed ID: 6447309
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind evaluation of zimelidine in comparison to placebo and amitriptyline in patients with major depressive disorder.
    Claghorn J; Gershon S; Goldstein BJ; Behrnetz S; Bush DF; Huitfeldt B
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):367-82. PubMed ID: 6225150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of zimelidine and norzimelidine in endogenous depression.
    Hansen LB; Thomsen IS; Vestergård P; Larsen NE; Hvidberg EF
    Psychopharmacology (Berl); 1980; 69(2):157-60. PubMed ID: 6450427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of the effect of the 5-HT-uptake inhibitor, zimelidine, on phobic anxiety.
    Koczkas S; Holmberg G; Wedin L
    Acta Psychiatr Scand Suppl; 1981; 290():328-41. PubMed ID: 6452799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline.
    Montgomery SA; Montgomery DB; McAuley R; Rani SJ; Roy D
    Adv Biochem Psychopharmacol; 1982; 32():35-42. PubMed ID: 6211942
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind controlled study of seratonin uptake inhibitor (Zimelidine) versus placebo in chronic pain patients.
    Johansson F; Von Knorring L
    Pain; 1979 Aug; 7(1):69-78. PubMed ID: 388295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double blind comparison of zimelidine and amitriptyline in endogenous depression.
    Montgomery SA; McAuley R; Rani SJ; Roy D; Montgomery DB
    Acta Psychiatr Scand Suppl; 1981; 290():314-27. PubMed ID: 6452798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A
    Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of zimelidine and amitriptyline in depressive out-patients.
    Syvälahti E; Salminen J; Lehtinen V
    J Int Med Res; 1982; 10(4):250-6. PubMed ID: 6214441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.